Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of different Gadovist MRI contrast application schemes in breast cancer
2010-018862-22Phase 2Completed
- Sponsor
- Kliniken Essen-Mitte
- Start
- Jun 2010
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gadobutrol in breast cancer, sponsored by Kliniken Essen-Mitte. Started Jun 2010; status: completed.
02
Drugs
gadobutrol
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-018862-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018862-22.